PBC治疗药物难治性原发性三叉神经痛的中远期疗效

doi:10.3760/cma.j.issn.1007-1245.2023.15.007

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (15): 2102-2105.DOI: 10.3760/cma.j.issn.1007-1245.2023.15.007

PBC治疗药物难治性原发性三叉神经痛的中远期疗效

赵长海¹ 哈尼克孜·肉孜¹ 法志强²

¹喀什地区第一人民医院疼痛科，喀什　844000；²南方医科大学珠江医院功能神经外科，广州　510282

收稿日期:2022-12-30 出版日期:2023-08-01 发布日期:2023-08-28
通讯作者: 法志强，Email：fzqqz@163.com
基金资助:
广东省科技计划项目（2017A030303020）

Mid- and long- term efficacy of PBC in the treatment of drug-resistant primary trigeminal neuralgia

Zhao Changhai¹, Rouzi Hanikez¹, Fa Zhiqiang²

¹Department of Pain Medicine, The First People's Hospital of Kashgar, Kashgar 844000, China; ²Department of Functional Neurosurgery, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China

Received:2022-12-30 Online:2023-08-01 Published:2023-08-28
Contact: Fa Zhiqiang, Email: fzqqz@163.com
Supported by:
Science and Technology Planned Project of Guangdong Province (2017A030303020

摘要/Abstract

摘要：

目的　探讨经皮穿刺三叉神经半月节微球囊压迫术（PBC）治疗药物难治性原发性三叉神经痛患者的中远期疗效和安全性。方法　回顾性研究2019年5月至11月喀什地区第一人民医院疼痛科采用PBC治疗的10例药物难治性原发性三叉神经痛患者（男5例、女5例，平均年龄66.8岁）的临床资料，患者出院后每6个月随访1次，采用视觉模拟评分法（VAS）、数字评价量表（NRS）评估患者的疼痛程度，记录患者的并发症和原发性三叉神经痛复发情况。末次随访时判断患者的疗效。采用Friedman M秩和检验、q检验。结果　10例PBC手术均获成功，出院后6个月随访时发现1例患者面部感觉减退，未予特殊处理，预后良好。随访过程中无复发患者，无咬肌无力、口周疱疹和角膜炎、复视等并发症发生。出院后3年末次随访时患者治疗有效率为100.0%（10/10）。患者术后即刻及出院后6个月、1年、1.5年、2年、2.5年、3年随访时VAS、NRS评分均低于术前，差异均有统计学意义（均P<0.05）。结论　PBC治疗药物难治性原发性三叉神经痛患者3年内安全、有效。

关键词:

原发性三叉神经痛, 经皮穿刺微球囊压迫术, 疗效, 安全性

Abstract:

Objective　To investigate the mid- and long- term efficacy and safety of percutaneous balloon compression (PBC) in the treatment of drug-resistant primary trigeminal neuralgia. Methods　The clinical data of 10 patients with drug-resistant primary trigeminal neuralgia who were treated with PBC in Department of Pain Medicine, The First People's Hospital of Kashgar from May to November 2019 were retrospectively analyzed, including 5 males and 5 females, with an average age of 66.8 years old. The patients were followed up every 6 months after discharge. The Visual Analogue Scale (VAS) and Numerical Rating Scale (NRS) were used to evaluate the patients' pain degree, and the complications and recurrence of primary trigeminal neuralgia were recorded. The curative effect was judged at the last follow-up. Friedman M rank sum test and q test were used. Results　All the 10 PBC surgeries had a smooth operation. At follow-up of 6 months after discharge, 1 patient was found to have facial hypoesthesia, and her prognosis was good without special treatment. During the follow-up, there were no recurrence and no complications such as chewing weakness, perioral herpes, keratitis, or diplopia. The effective rate was 100.0% (10/10) at the last follow-up of 3 years after discharge. The patients' VAS and NRS scores were decreased immediately after surgery and 6 months, 1 year, 1.5 years, 2 years, 2.5 years, and 3 years after discharge compared with those before surgery, with statistically significant differences (all P<0.05). Conclusion　PBC is safe and effective in the treatment of drug-resistant primary trigeminal neuralgia in about 3 years.

Key words:

Primary trigeminal neuralgia, Percutaneous balloon compression, Curative effect, Safety

赵长海哈尼克孜·肉孜法志强.

PBC治疗药物难治性原发性三叉神经痛的中远期疗效 [J]. 国际医药卫生导报, 2023, 29(15): 2102-2105.

Zhao Changhai, Rouzi Hanikez, Fa Zhiqiang.

Mid- and long- term efficacy of PBC in the treatment of drug-resistant primary trigeminal neuralgia [J]. International Medicine and Health Guidance News, 2023, 29(15): 2102-2105.

参考文献

[1] Sharma R, Phalak M, Katiyar V, et al. Microvascular decompression versus stereotactic radiosurgery as primary treatment modality for trigeminal neuralgia: a systematic review and meta-analysis of prospective comparative trials[J].Neurol India,2018,66(3):688-694.DOI:10.4103/0028-3886.232342.
[2] 应翔,沈煜豪,王昊,等. 经皮穿刺微球囊压迫术治疗80岁以上老年病人三叉神经痛的疗效分析[J]. 中国疼痛医学杂志,2018,24(2):107-111. DOI:10.3969/j.issn.1006-9852. 2018.02.005.
[3] Asplund P, Linderoth B, Lind G, et al. One hundred eleven percutaneous balloon compressions for trigeminal neuralgia in a cohort of 66 patients with multiple sclerosis[J].Oper Neurosurg (Hagerstown),2019,17(5):452-459. DOI:10.1093/ons/opy402.
[4] 谢可越,黄冰. CT引导清醒局麻下经皮微球囊压迫术治疗难治性三叉神经第Ⅰ、Ⅱ支痛高龄患者一例[J]. 中华疼痛学杂志,2021,17(1):94-98. DOI:10.3760/cma.j.cn101379-20191104-00077.
[5] Régis J, Tuleasca C, Resseguier N, et al. The very long-term outcome of radiosurgery for classical trigeminal neuralgia[J]. Stereotact Funct Neurosurg,2016,94(1):24-32.DOI:10.1159/000443529.
[6] Yayama T, Kobayashi S, Nakanishi Y, et al. Effects of graded mechanical compression of rabbit sciatic nerve on nerve blood flow and electrophysiological properties[J].J Clin Neurosci,2010,17(4):501-505.DOI:10.1016/j.jocn.2009.07.110.
[7] Li F, Han S, Ma Y, et al. Optimal duration of percutaneous microballoon compression for treatment of trigeminal nerve injury[J].Neural Regen Res,2014,9(2):179-189.DOI:10.4103/1673-5374.125347.
[8] 程森,王冰冰,寿记新,等. 经皮穿刺微球囊压迫术治疗药物难治性三叉神经痛的临床疗效[J]. 中国实用神经疾病杂志,2019,22(7):725-731.DOI:10.12083/SYSJ.2019.07.086.
[9] 胡强,俞文华,杜权,等. 微血管减压术与经皮穿刺球囊压迫治疗复发三叉神经痛的疗效比较[J]. 临床神经外科杂志,2018,15(1):26-30,33. DOI:10.3969/j.issn.1672-7770. 2018.01.006.
[10] 何睿林,韦艳红,胡鑫,等. 不同压迫时长对经皮穿刺球囊压迫术治疗原发性三叉神经痛疗效的影响[J]. 中华疼痛学杂志,2021,17(1):28-35.DOI:10.3760/cma.j.cn101658- 20201015-00182.
[11] 郑碧鑫,宋莉,刘慧. 微创介入技术治疗原发性三叉神经痛的研究进展[J]. 国际麻醉学与复苏杂志,2019,40(7):689-693. DOI:10.3760/cma.j.issn.1673-4378.2019. 07.017.
[12] 李景辉,毕莉莉,卜凡贵,等. 球囊压力与压迫时间对经皮穿刺微球囊压迫术治疗三叉神经痛疗效的临床研究[J]. 中国保健营养,2021,31(31):48.
[13] 俞文华. 影响经皮穿刺球囊压迫术治疗三叉神经痛疗效的因素[J]. 实用医学杂志,2014,30(21):3379-3380. DOI:10.3969/j.issn.1006-5725.2014.21.003.
[14] 王飞. PBC治疗三叉神经痛术中球囊压力与术后并发症、复发的相关性探究[D].兰州:甘肃中医药大学,2022.

[1]	温诗瑜温炬冯颖君李慕锦秦思. 生物制剂在银屑病中的临床应用 [J]. 国际医药卫生导报, 2023, 29(9): 1185-1188.
[2]	张利敏. 卡前列素氨丁三醇对凶险性前置胎盘的治疗效果及对妊娠结局的影响 [J]. 国际医药卫生导报, 2023, 29(9): 1253-1257.
[3]	窦东锋刘洪光张丽芬. 单硝酸异山梨酯联合培哚普利叔丁胺治疗老年慢性心力衰竭患者的疗效 [J]. 国际医药卫生导报, 2023, 29(9): 1276-1280.
[4]	康杰张建建张伟东张岳黄杲德. 尼可地尔联合二甲双胍治疗2型糖尿病合并冠心病患者的疗效和安全性观察 [J]. 国际医药卫生导报, 2023, 29(7): 936-939.
[5]	李会林. 通心络与参松养心胶囊联合常规西药治疗室性心律失常患者的效果 [J]. 国际医药卫生导报, 2023, 29(7): 944-947.
[6]	刘文新李同民郭东霞李真真张轶清. 卵巢髓系肉瘤1例报道并文献分析 [J]. 国际医药卫生导报, 2023, 29(5): 700-702.
[7]	刘晓卉. 小剂量硝酸甘油联合氯吡格雷治疗冠心病心绞痛患者的疗效及安全性评价 [J]. 国际医药卫生导报, 2023, 29(4): 549-553.
[8]	刘辉王珍珍赵亚非. 临床药师参与的用药管理对急性脑梗死介入术后患者用药规范性、用药依从性及安全性的影响 [J]. 国际医药卫生导报, 2023, 29(4): 564-568.
[9]	毋琳琳. 自由体位下罗哌卡因、舒芬太尼在瘢痕子宫再次分娩中的镇痛效果及安全性 [J]. 国际医药卫生导报, 2023, 29(3): 361-364.
[10]	吴石兵孟庆叶陈婷郭峰. 银离子抗菌功能性敷料联合NPWT治疗慢性感染性创面的效果分析 [J]. 国际医药卫生导报, 2023, 29(14): 1967-1971.
[11]	高宇峰陈志飞许艳华朱房勇吴祥冰侯德强. 数字化导板在种植二期手术与常规切开手术中的临床疗效比较 [J]. 国际医药卫生导报, 2023, 29(14): 1971-1974.
[12]	沙莎杨秋敏. 不同PD-1抑制剂治疗胃肠道肿瘤的临床效果 [J]. 国际医药卫生导报, 2023, 29(13): 1828-1831.
[13]	李桢邹姒妮李聪. 连续性血液净化对脓毒症患儿的疗效及其对血清炎症指标的影响 [J]. 国际医药卫生导报, 2023, 29(13): 1856-1859.
[14]	刘宁郑学燕董敏孙宝莲. 银杏叶滴丸联合缬沙坦胶囊治疗老年高血压患者的效果观察 [J]. 国际医药卫生导报, 2023, 29(12): 1674-1677.
[15]	陈丽丽朱成宝. 眼底激光联合IVR治疗RVO-ME患者的疗效观察 [J]. 国际医药卫生导报, 2023, 29(12): 1703-1707.

PBC治疗药物难治性原发性三叉神经痛的中远期疗效

Mid- and long- term efficacy of PBC in the treatment of drug-resistant primary trigeminal neuralgia

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics